American Herbal Products Association (AHPA) > News > Latest News

AHPA Presents at Korea-China Joint International Phytonutrient Symposium

AHPA President Michael McGuffin presents overview of regulatory landscape for botanical raw materials

AHPA President Michael McGuffin presented an overview of U.S. regulations for botanical raw materials at the 2016 Korea-China Joint International Phytonutrient Symposium organized jointly by the Korean Society of Food Science and Technology (KoSFoST) and the Chinese Nutrition Society and held on October 27 in Seoul, Korea.

Update on international supplement regulations

IADSA October 2016 Newsflash

IADSA is an association focused on the globalization of food supplement markets and regulatory challenges. This issue of the IADSA Newsflash includes an update on the European Commission (EC) request of the European Food Safety Authority (EFSA) to provide a scientific opinion on the safety of green tea catechins with a proposed deadline of October 2017.

"Incidental DNA fragments" may be misinterpreted using Next Generation Sequencing (NGS)

A caution to industry and regulators

This article, "A caution to industry and regulators - 'Incidental DNA fragments' may be misinterpreted using Next Generation Sequencing (NGS)," is authored by Dr. Steven Newmaster, Professor, Botany & Genetics/Genomics at the University of Guelph, Dr. Subramanyam Ragupathy, Senior Scientist, NHP Molecular Diagnostics at the Biodiversity Institute of Ontario, and Dr. Robert Hanner, Chief Technology Officer (CTO) at TRU-ID Ltd. These leading DNA experts detai challenges and pitfalls of DNA analysis used to verify the identity of herbal ingredients.

California Prop 65 Webinar: A Status Update

Companies selling products in California should understand recent and developing Prop 65 changes

Recorded November 16, 2016. Member cost: $220. Nonmember cost: $520.

Herbal supplement industry's long history of self-regulation in the October AHPA Report!

October 2016

AHPA expresses concern about DEA using emergency scheduling authority to temporarily classify herb as schedule I substance

AHPA requests DEA to delay action

The American Herbal Products Association (AHPA) sent a letter to the U.S. Drug Enforcement Agency (DEA) urging the agency to reconsider using its emergency scheduling authority to temporarily place constituents of the herb kratom into schedule I of the Controlled Substances Act (CSA).

Biennial food facility registration renewal begins October 1

Facilities must register by December 1

Domestic and foreign facilities that manufacture, process, pack, or hold food for consumption in the United States are required to register with the Food and Drug Administration (FDA). All entities required to register must renew their registration from October 1 through December 31 every even-numbered year. If the facility registration is not renewed by 11:59 PM on December 31, 2016, the registration is considered expired.

Takeaways from AHPA's NDI draft guidance webinar in the September AHPA Report!

September 2016

FDA Seeks Comment on Tentative Conclusion that Vinpocetine Is not a Dietary Ingredient

FDA maintains vinpocetine is a synthetic compound

A Food and Drug Administration (FDA) notice scheduled to be published tomorrow in the Federal Register requests comments on the agency's tentative conclusion that vinpocetine is not a dietary ingredient and is excluded from the definition of a dietary supplement.

Report from the 2016 Conference of Western Attorneys General Annual Meeting

By Douglas F. Gansler

In January, AHPA and UNPA launched a joint campaign to develop working relationships with state attorneys general (AG) and educate them about the herbal supplement industry to ensure they have an accurate understanding of the industry. Former Maryland Attorney General  and Past President of the National Association of Attorneys General. Gansler was hired to help deliver information and expertise about the industry to his colleagues.
RSS
First 234567891011 Last

2017 Annual Fund Sponsors

           

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.